A drug which is said to "reboot" the immune system has been shown to be an effective treatment for multiple sclerosis (MS), a study has found.
The results of the trials were so encouraging in reducing the number of attacks in those affected that the MS Society is campaigning for the drug to become available on the NHS.
The research showed that alemtuzumab significantly reduced the number of attacks or relapses by people with MS compared to the current drug interferon beta-1a which is known commercially as Rebif.
More top news
By the time all the dead are counted, it will have grown to a great chorus of grief, Africa Correspondent John Ray reports.
For years we’ve been told to stay out of the hot summer sun. So how much sun is too much? Kylie Pentelow looks at the latest advice.
The Rotherham MP's piece appeared under a headline which read: 'British Pakistanis are raping white girls.'